# US 2013/0153419 A1 · Generation of engineered molecular weight standards

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0153419 A1
- Document ID: US20130153419A1
- Status: Published application
- Kind: A1
- Application number: 13/331,946
- Filed: 2011-12-20
- Published: 2013-06-20
- Earliest claimed: 2011-12-20
- Assignees: Bio-Rad Laboratories, Inc.
- Inventors: LEI LI; DENNIS YEE
- Web page: https://patentgrep.com/patent/US20130153419A1

## CPC

- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

The invention provides methods of generating physical analog polypeptides, and polypeptides generated employing the methods of the invention, that have the same amino acid composition of a reference protein, but have an unrelated primary sequence. The invention further provides compositions and methods employing such proteins.

## Claims

### Claim 1

An engineered protein comprising a physical analog of a reference protein amino acid sequence, wherein the analog: (i) has the same amino acid composition as the reference protein sequence; and (ii) has a primary sequence that has less than 50% identity to the reference protein sequence.

### Claim 2 (depends on 1)

The engineered protein of claim 1, wherein the reference protein sequence is at least 80 amino acids in length.

### Claim 3

(canceled)

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The engineered protein of claim 1, wherein the physical analog comprises a reversed sequence of at least 25 amino acids in length, or at least 50 amino acids in length, relative to a reference protein sequence.

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The engineered protein of claim 1, wherein the physical analog comprises a scrambled sequence of at least 25 amino acids in length, or at least 50 amino acids in length, relative to a reference protein sequence.

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The engineered protein of claim 1, wherein the engineered protein comprises at least two repeated physical analog sequences.

### Claim 10

An engineered polypeptide that comprises an amino acid sequence having at least 80% identity to an amino acid sequence set forth in SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, or SEQ ID NO:8; wherein the protein characterized by the amino acid sequence retains the same charge and molecular weight as a reference protein set forth in SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5, or SEQ ID NO:7.

### Claim 11

A molecular weight marker composition comprising an aqueous solution and at least one engineered polypeptide comprising a physical analog of a reference protein amino acid sequence, wherein the analog: (i) has the same amino acid composition as the reference protein sequence; and (ii) has a primary sequence that has less than 50% identity to the reference protein sequence.

### Claim 12 (depends on 11)

The molecular weight marker composition of claim 11, wherein the reference protein sequence is at least 80 amino acids in length.

### Claim 13

(canceled)

### Claim 14

(canceled)

### Claim 15 (depends on 11)

The molecular weight marker composition of claim 11 wherein the physical analog comprises a reversed sequence of at least 25 amino acids in length, or at least 50 amino acids in length, relative to a reference protein sequence.

### Claim 16

(canceled)

### Claim 17 (depends on 11)

The molecular weight marker composition of claim 11, wherein the physical analog comprises a scrambled sequence of at least 25 amino acids in length, or at least 50 amino acids in length, relative to a reference protein sequence.

### Claim 18

(canceled)

### Claim 19 (depends on 17)

The molecular weight marker composition of claim 17, wherein the engineered protein comprises at least two repeated physical analog sequences.

### Claim 20

A molecular weight marker composition that comprises an engineered polypeptide that comprises an amino acid sequence having at least 80% identity to an amino acid sequence set forth in SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, or SEQ ID NO:8; wherein the protein characterized by the amino acid sequence retains the same charge and molecular weight as a reference protein set forth in SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5, or SEQ ID NO:7.

### Claim 21 (depends on 11)

The molecular weight marker composition of claim 11, wherein the composition comprises at least a second engineered polypeptide comprising a physical analog.

### Claim 22 (depends on 11)

The molecular weight marker composition of claim 11, further comprising molecular weight markers that provide a range from 10 kD to 250 kD in size.

### Claim 23 (depends on 11)

A kit comprising a molecular weight marker composition of claim 11.

### Claim 24 (depends on 11)

A method of determining the size of a protein present in a sample, the method comprising electrophoresing the protein under denaturing conditions; electrophoresing a molecular weight marker composition of claim 11; and comparing the size of the protein in the samples to the molecular weight markers present in the molecular weight marker composition, thereby determining the size of the protein present in the sample.

### Claim 25 (depends on 1)

A method of preparing a molecular weight marker composition, the method comprising: expressing a nucleic acid encoding an engineered protein of claim 1 in a bacterial host cell; and purifying the recombinant protein.

### Claim 26 (depends on 25)

The method of claim 25, further comprising admixing the recombinant protein with at least one other protein molecular weight marker.

### Claim 27 (depends on 25)

The method of claim 25, further comprising admixing the recombinant protein with molecular weight marker proteins of different sizes to provide a range of molecular weight marker proteins having molecule weights from about 3.0 to about 250 kDa.

### Claim 28

A method of generating a physical analog polypeptide, the method comprising providing a reference protein sequence;
reversing and/or scrambling a subsequence of the reference protein to obtain a physical analog sequence wherein the analog sequence: (i) has the same amino acid composition as the reference protein sequence; and (ii) has a primary sequence that has less than 50% identity to the reference protein sequence; and
synthesizing a protein comprising the physical analog polypeptide.

### Claim 29 (depends on 28)

The method of claim 28, wherein the reference protein sequence is at least 80 amino acids in length

### Claim 30 (depends on 28)

The method of claim 28, wherein a subsequence of at least 25 amino acids in length, or at least 50 amino acids in length, is scrambled or reversed
